ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
European Lung Cancer Congress 2020
15 - 18 Apr 2020
-, Geneva, Switzerland
Background of the KEYNOTE-158 trial for pembrolizumab in advanced mesothelioma
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Preclinical models for small-cell lung cancer
Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands
Do immune checkpoint inhibitors work in EGFR mutant lung cancer?
Dr Edward Garon - UCLA Medical Center, Santa Monica, USA
Managing toxicities associated with immune-checkpoint inhibitors
Prof Olivier Lambotte - Hôpitaux de Paris, Paris, France
New oncogenic drivers in NSCLC
Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands
The potential of KRAS inhibitors for non-small-cell lung cancer
Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany